Hillhouse Capital Advisors, Ltd.
13F Reported Value
ⓘ$832.1M
Holdings
35
Latest Filing
2026-06-30
Filing Quarter
Q2 2026
Portfolio Overview
Hillhouse Capital Advisors, Ltd. disclosed 35 positions worth $832.1M in its Form 13F-HR for Q2 2026, led by $LEGN (Legend Biotech Corp) at 20.8% of the equity portfolio, followed by $FUTU and $AVBP. During the quarter the fund opened 6 new positions and exited 9 — including a new stake in $ALMR and a full exit from $ONC. The portfolio is most concentrated in Healthcare (43.9% of disclosed assets). All figures are sourced directly from Hillhouse Capital Advisors, Ltd.’s Form 13F-HR filing with the SEC under CIK 1762304.
AI Fund Analysis
DiversifyingSector Allocation
AUM History
Top Equity Holdings by Value
Quarterly Activity — Q2 2026
Click any card to unlockTop Holdings
- 47.8#1,761
Quality
$172.8M5,984,550 sh - —
Quality
$165.8M1,768,283 sh - —
Quality
$136.5M3,929,117 sh - 76.5
Quality
$48.5M162,933 sh - —
Quality
$46.0M3,470,400 sh - —
Quality
$38.1M500,000 sh - —
Quality
$32.2M2,218,377 sh - 21.4
Quality
$29.5M6,657,030 sh - —
Quality
$25.9M956,462 sh - —
Quality
$17.7M183,934 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
| 47.8#1,761 | $172.8M | 5,984,550 | |
| — | $165.8M | 1,768,283 | |
| — | $136.5M | 3,929,117 | |
| 76.5 | $48.5M | 162,933 | |
| — | $46.0M | 3,470,400 | |
| — | $38.1M | 500,000 | |
| — | $32.2M | 2,218,377 | |
| 21.4 | $29.5M | 6,657,030 | |
| — | $25.9M | 956,462 | |
| — | $17.7M | 183,934 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of Hillhouse Capital Advisors, Ltd.'s 35 positions.
Showing top 10 of 35 holdings.
Sector Allocation
Healthcare
$365.3M
Financials
$167.8M
Technology
$144.6M
Industrials
$57.2M
Consumer Discretionary
$46.0M
Real Estate
$32.2M
Consumer Staples
$15.5M
Materials
$3.4M
Full Holdings — Hillhouse Capital Advisors, Ltd. (Q2 2026)
All 35 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | Legend Biotech Corp | $172.8M | 20.8% | +0% | 47.8 | |
| 2 | Futu Holdings Ltd | $165.8M | 19.9% | +25% | — | |
| 3 | ArriVent BioPharma, Inc. | $136.5M | 16.4% | +0% | — | |
| 4 | Marvell Technology, Inc. | $48.5M | 5.8% | -5% | 76.5 | |
| 5 | Vipshop Holdings Ltd | $46.0M | 5.5% | +2683% | — | |
| 6 | PDD Holdings Inc. | $38.1M | 4.6% | -88% | — | |
| 7 | KE Holdings Inc. | $32.2M | 3.9% | -48% | — | |
| 8 | Cytek Biosciences, Inc. | $29.5M | 3.5% | +0% | 21.4 | |
| 9 | Alamar Biosciences, Inc. | $25.9M | 3.1% | NEW | — | |
| 10 | Alibaba Group Holding Ltd | $17.7M | 2.1% | -93% | — | |
| 11 | Odyssey Therapeutics, Inc. | $15.6M | 1.9% | NEW | — | |
| 12 | Yatsen Holding Ltd | $15.5M | 1.9% | +0% | — | |
| 13 | NovaBridge Biosciences | $11.7M | 1.4% | +0% | — | |
| 14 | Contineum Therapeutics, Inc. | $11.0M | 1.3% | +0% | — | |
| 15 | Maze Therapeutics, Inc. | $10.9M | 1.3% | +0% | 10.3 | |
| 16 | Agora, Inc. | $8.4M | 1.0% | +0% | — | |
| 17 | TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD | $7.4M | 0.9% | -0% | — | |
| 18 | Sagimet Biosciences Inc. | $5.6M | 0.7% | +0% | — | |
| 19 | NetEase, Inc. | $4.5M | 0.5% | NEW | — | |
| 20 | GENERAL ELECTRIC CO | $3.8M | 0.5% | +0% | 73.8 | |
| 21 | Lumentum Holdings Inc. | $2.8M | 0.3% | +120% | 44.3 | |
| 22 | NVIDIA CORP | $2.8M | 0.3% | +113% | 85.9 | |
| 23 | Tuya Inc. | $2.8M | 0.3% | +0% | — | |
| 24 | CORNING INC /NY | $2.6M | 0.3% | +33% | 73.7 | |
| 25 | COHERENT CORP. | $2.5M | 0.3% | +50% | 58.5 | |
| 26 | Webull Corp | $2.0M | 0.2% | -79% | 33.5 | |
| 27 | INTEL CORP | $2.0M | 0.2% | -51% | 45.6 | |
| 28 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | $1.5M | 0.2% | +0% | 17.1 | |
| 29 | TEXAS INSTRUMENTS INC | $1.4M | 0.2% | NEW | 73.4 | |
| 30 | MOGU Inc. | $1.4M | 0.2% | +0% | — | |
| 31 | Gossamer Bio, Inc. | $818,727 | 0.1% | +0% | 8.2 | |
| 32 | Equinox Gold Corp. | $782,460 | 0.1% | +0% | — | |
| 33 | Zoom Communications, Inc. | $777,653 | 0.1% | NEW | 70.5 | |
| 34 | Aligos Therapeutics, Inc. | $439,945 | 0.1% | +0% | — | |
| 35 | — | RIDGETECH INC - SHS NEW | $204 | 0.0% | NEW | — |
New Positions (6)
Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for Hillhouse Capital Advisors, Ltd. including:
Track Hillhouse Capital Advisors, Ltd.'s Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for Hillhouse Capital Advisors, Ltd. and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: Hillhouse Capital Advisors, Ltd.
13F Pro is an AI hedge fund tracker and stock research platform. For Hillhouse Capital Advisors, Ltd. (SEC CIK: 1762304), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in Hillhouse Capital Advisors, Ltd.'s portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.